Participants 125 184 6
'high risk' pre- and postmenopausal breast cancer patients.
Participants 274 321 6
node positive breast cancer patients in Sweden.
Participants 625 748 6
pre- (n = 547) and postmenopausal (n = 679) patients, respectively, with node positive disease or a tumour diameter > 30 mm
